Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

IMPORTANCE: Neuromyelitis optica (NMO) is an inflammatory disease of the optic nerves and spinal cord that leads to blindness and paralysis. Effective immunosuppression is the standard of care for relapse prevention. OBJECTIVE: To compare the relapse and treatment failure rates among patients receiv...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Mealy, M, Wingerchuk, D, Palace, J, Greenberg, B, Levy, M
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2014

Eitemau Tebyg

Treatment of Neuromyelitis Optica: Review and Recommendations.
gan: Kimbrough, D, et al.
Cyhoeddwyd: (2012)

Treatment of neuromyelitis optica: Review and recommendations
gan: Kimbrough, D, et al.
Cyhoeddwyd: (2012)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
gan: Tackley, G, et al.
Cyhoeddwyd: (2016)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
gan: Elsone, L, et al.
Cyhoeddwyd: (2012)

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
gan: Levy M, et al.
Cyhoeddwyd: (2021-08-01)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
gan: Palace, J, et al.
Cyhoeddwyd: (2010)

Seasonal pattern of variation in neuromyelitis optica relapses
gan: Elsone, L, et al.
Cyhoeddwyd: (2012)

A practical guide to the treatment of neuromyelitis optica.
gan: Palace, J, et al.
Cyhoeddwyd: (2012)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
gan: Achim Berthele, et al.
Cyhoeddwyd: (2023-04-01)

Prognosis of Relapsing Neuromyelitis Optica
gan: J Gordon Millichap
Cyhoeddwyd: (2003-03-01)

Relapsing neuromyelitis optica spectrum disorder
gan: M Lakshmi Lavanya, et al.
Cyhoeddwyd: (2021-01-01)

The borderland of neuromyelitis optica.
gan: Matthews, L, et al.
Cyhoeddwyd: (2009)

Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
gan: Sedani, S, et al.
Cyhoeddwyd: (2012)

Racial differences in neuromyelitis optica spectrum disorder
gan: Kim, S, et al.
Cyhoeddwyd: (2018)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
gan: Kitley, J, et al.
Cyhoeddwyd: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
gan: Kitley, J, et al.
Cyhoeddwyd: (2014)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
gan: Pittock, S, et al.
Cyhoeddwyd: (2019)

Use of mitoxantrone in neuromyelitis optica.
gan: Kitley, J, et al.
Cyhoeddwyd: (2011)

Treatment strategies for neuromyelitis optica
gan: Tzu-Lun Huang, et al.
Cyhoeddwyd: (2018-01-01)

Magnetic resonance imaging in neuromyelitis optica.
gan: Tackley, G, et al.
Cyhoeddwyd: (2014)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
gan: Waters, P, et al.
Cyhoeddwyd: (2015)

Observation of the efficacy of ofatumumab in the treatment of neuromyelitis optica spectrum disorders
gan: ZHANG Rui, et al.
Cyhoeddwyd: (2024-06-01)

Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
gan: Bo Chen, et al.
Cyhoeddwyd: (2017-04-01)

Advances in the long-term treatment of neuromyelitis optica spectrum disorder
gan: Monique Anderson, et al.
Cyhoeddwyd: (2024-01-01)

The evolving clinical spectrum of neuromyelitis optica
gan: Viegas, S, et al.
Cyhoeddwyd: (2008)

Clinical evaluation of rituximab treatment for neuromyelitis optica
gan: M.J. Fernández-Megía, et al.
Cyhoeddwyd: (2015-10-01)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
gan: Matthews, L, et al.
Cyhoeddwyd: (2014)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
gan: Fujihara, K, et al.
Cyhoeddwyd: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
gan: Matthews, L, et al.
Cyhoeddwyd: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
gan: Waters, P, et al.
Cyhoeddwyd: (2016)

Treatment response, risk of relapse and clinical characteristics of Taiwanese patients with neuromyelitis optica spectrum disorder
gan: Yi-Hong Liu, et al.
Cyhoeddwyd: (2022-09-01)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
gan: Collongues, N, et al.
Cyhoeddwyd: (2013)

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
gan: Akiyuki Uzawa, et al.
Cyhoeddwyd: (2011-01-01)

Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort
gan: Denis Bernardi Bichuetti, et al.
Cyhoeddwyd: (2015-02-01)

Review: Treatment of neuromyelitis optica: Current debate
gan: Tomoko Okamoto, et al.
Cyhoeddwyd: (2008-07-01)

Treatment of neuromyelitis optica: an evidence based review
gan: Douglas Sato, et al.
Cyhoeddwyd: (2012-01-01)

Current and future treatment approaches for neuromyelitis optica
gan: Nicolas Collongues, et al.
Cyhoeddwyd: (2011-03-01)

A mathematical model of cellular swelling in Neuromyelitis optica
gan: Laranjeira, S, et al.
Cyhoeddwyd: (2017)

Neuromyelitis Optica
gan: Goyal V, et al.
Cyhoeddwyd: (2009-10-01)

Neuromyelitis optica
gan: Jacob Anu, et al.
Cyhoeddwyd: (2007-01-01)